logo

LIMN

Liminatus Pharma·NASDAQ
--
--(--)
--
--(--)
2.04 / 10
Underperform

Technical analysis composite is weak, with a score of 2.04/10. Dominant bearish signals include a MACD Death Cross, frequent Long Upper Shadow patterns, and an RSI in overbought territory. These indicators collectively suggest downward momentum and caution. Although a MACD Golden Cross appeared briefly, its impact is outweighed by the broader negative trend. Traders may consider waiting for a clear bullish reversal before entering positions.

FundamentalSentimentTechnical(2.04)

Analysis Checks(0/5)

Long Upper Shadow
Score1/10
Win Rate34.57%
Hist. Signals81
Avg Return-0.85%
Long Lower Shadow
Score1/10
Win Rate29.58%
Hist. Signals71
Avg Return1.82%
RSI Overbought
Score2.87/10
Win Rate50.00%
Hist. Signals4
Avg Return-16.95%
MACD Death Cross
Score3.54/10
Win Rate50.00%
Hist. Signals6
Avg Return-0.52%
MACD Golden Cross
Score1.77/10
Win Rate28.57%
Hist. Signals7
Avg Return37.70%
Technical Analysis of LIMN?
  • LIMN presents a Underperform setup with a Technical Score of 2.04/10. Key technical indicators highlight an RSI of 74.74 and a MACD of 0.29, with the trend anchored by the 50-Day SMA at 0.84. Traders should monitor key support at 1.56 and resistance at 2.52.